Literature DB >> 8144889

Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401.

C M Hill1, A Liu, K W Marshall, J Mayer, B Jorgensen, B Yuan, R M Cubbon, E A Nichols, L S Wicker, J B Rothbard.   

Abstract

The individual amino acid contacts responsible for peptide binding to DRB1*0101 and/or DRB1*0401 were defined using a quantitative binding assay. The differential contribution of each amino acid in two well studied T cell determinants, HA307-319 and RMBP 90-102, was delineated by comparing the IC50 values of analogues of varying length. This analysis confirmed the importance of a hydrophobic amino acid located near the amino-terminus for binding to both alleles and revealed that the contribution of the carboxyl-terminal amino acids differed between DRB1*0101 and DRB1*0401. Taking advantage of previous experiments demonstrating that all of the residues could be replaced with alanine, with the exception of the key hydrophobic amino acid, simplified analogues composed of polyalanines were used to prove 1) optimal binding depended on the position of the hydrophobic side chain relative to the amino- and carboxyl-termini; 2) aromatic amino acids were superior to aliphatic side chains at this position; and 3) a significant amount of free energy of binding arises from hydrogen bonding between the class II binding site and the amide bonds of the ligand. The role of each carbonyl and amide nitrogen was measured by assaying analogues containing reduced peptide bonds or N-methyl amino acids. Serine, but not glycine, could be used as a framework amino acid for peptide ligands, indicating that the beneficial aspects of these simplified structures was the combination of retaining the correct orientation of the peptide bonds, the restriction of the conformational freedom by limiting the possible phi/psi angles of the peptide, and avoidance of deleterious side-chain contacts. Collectively, these data were consistent with the peptide binding in a nonrepeating conformation with the vast majority of the free energy of binding arising from hydrogen bonds with the peptide backbone and a single, key hydrophobic side chain interacting in a conserved pocket in both DRB1*0101 and DRB1*0401.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144889

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells.

Authors:  Azizul Haque; Laela M Hajiaghamohseni; Ping Li; Katherine Toomy; Janice S Blum
Journal:  Cell Immunol       Date:  2007-12-11       Impact factor: 4.868

2.  Memory T cells specific to citrullinated α-enolase are enriched in the rheumatic joint.

Authors:  Jennifer Pieper; Anatoly Dubnovitsky; Christina Gerstner; Eddie A James; Mary Rieck; Genadiy Kozhukh; Karolina Tandre; Sara Pellegrino; John A Gebe; Lars Rönnblom; Tatyana Sandalova; William W Kwok; Lars Klareskog; Jane H Buckner; Adnane Achour; Vivianne Malmström
Journal:  J Autoimmun       Date:  2018-05-28       Impact factor: 7.094

3.  Quantitative analysis of peptides from myelin basic protein binding to the MHC class II protein, I-Au, which confers susceptibility to experimental allergic encephalomyelitis.

Authors:  L Fugger; J Liang; A Gautam; J B Rothbard; H O McDevitt
Journal:  Mol Med       Date:  1996-03       Impact factor: 6.354

4.  Role of polymorphic residues of human leucocyte antigen-DR molecules on the binding of human immunodeficiency virus peptides.

Authors:  S Jurcevic; C Praud; H L Coppin; A Bertrand; S Ricard; M Thomsen; F Lakhdar-Ghazal; C De Preval
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

5.  Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.

Authors:  B S Nepom; G T Nepom; M Coleman; W W Kwok
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

6.  Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.

Authors:  John Sidney; Scott Southwood; Carrie Moore; Carla Oseroff; Clemencia Pinilla; Howard M Grey; Alessandro Sette
Journal:  Curr Protoc Immunol       Date:  2013-02

7.  Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients.

Authors:  Omri Snir; Mary Rieck; John A Gebe; Betty B Yue; Crystal A Rawlings; Gerald Nepom; Vivianne Malmström; Jane H Buckner
Journal:  Arthritis Rheum       Date:  2011-10

8.  Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.

Authors:  Jason M God; Dan Zhao; Christine A Cameron; Shereen Amria; Jennifer R Bethard; Azizul Haque
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

9.  Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.

Authors:  J L Dzuris; J Sidney; H Horton; R Correa; D Carter; R W Chesnut; D I Watkins; A Sette
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Antigen-specific CD4+ T cells recognize epitopes of protective antigen following vaccination with an anthrax vaccine.

Authors:  Elsa M Laughlin; Joseph D Miller; Eddie James; Dimitri Fillos; Chris C Ibegbu; Robert S Mittler; Rama Akondy; William Kwok; Rafi Ahmed; Gerald Nepom
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.